Skip to main content

Table 2 c-erbB-2 score evaluations

From: The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas

   c-erbB-2 score  
   Negative
n (%)
Positive
n (%)
P†
Menstrual Status Premenopausal 16 (72,7) 6 (27,3)  
  Postmenopausal 43 (86) 7 (14) 0,177
Histological Grade Grade 1 22 (88) 3 (12) 0,484
  Grade 2 30 (76,9) 9 (23,1)  
  Grade 3 7 (87,5) 1 (12,5)  
Invasion Depth <1/2 31 (75,6) 10 (24,4) 0,243
  >1/2 23 (92) 2 (8)  
  Limited to endometrium 5 (83,3) 1 (16,7)  
Lymph Node Status Positive 3 (75) 1 (25) 0,615
  Negative 28 (93,3) 2 (6,7)  
Stage I 26 (92,9) 2 (7,1)  
  II 1 (100) 0 (0)  
  III 4 (80) 1 (20)  
Estrogen Positive 52 (85,2) 9 (14,8) 0,086
  Negative 7 (63,6) 4 (36,4)  
Progesterone Positive 51 (86,4) 8 (13,6) 0,035
  Negative 8 (61,5) 5 (38,5)  
Survival Alive 36 (81,82) 8 (18,18) 0,215
  Death 5 (100) 0 (0)  
  1. †: Chi square test. p < 0,05 significant; p > 0,005 insignificant